Physician profile
John D Carroll
NPI 1063502748
$25,469.50
in general payments reported to CMS, 2019-2025
9 companies · $23.45 in 2025
The $23.45 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,745 · 2020: $7,200 · 2021: $6,117 · 2022: $4,933 · 2023: $825 · 2024: $627 · 2025: $23.45.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,253 · Food and Beverage: $222.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,253.00 |
| Food and Beverage | $222.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $15,543.16 | 2019-2025 | Amplatzer Talisman, Amplatzer, Mitraclip |
| Edwards Lifesciences Corporation | $5,299.29 | 2019-2022 | |
| Philips North America LLC | $3,154.60 | 2020-2022 | |
| Boston Scientific Corporation | $914.33 | 2019 | |
| Medtronic, INC. | $167.97 | 2022 | |
| Heartflow, INC. | $154.61 | 2019 | |
| Medtronic Vascular, INC. | $126.57 | 2019 | |
| W. L. Gore & Associates, INC. | $77.50 | 2019 | |
| Shockwave Medical, INC | $31.47 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Carroll listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.